Inflammatory mediators found in the CF airways such as TNF-α, IL-1β, and IL-17 have been shown to augment CFTR modulator efficacy in cultured cells (54, 55) and their higher baseline levels correlate with improved ppFEV1 after ivacaftor (54). This evidence concerns the gene CFTR and cystic fibrosis.